Patent ID: 9717691
Date: 2017-08-01
CPC Classifications: A61K,A61P

Claim:
1. A dosage form comprising a medicament containing an active ingredient combination consisting of a hormone combination with contraceptive action, said hormone combination consisting of at least one oestrogen selected from the group consisting of estradiol and ethinyl estradiol and at least one gestagen selected from the group consisting of chlormadinone acetate, 3-β-OH-chlormadinone acetate, 3-α-OH-chlormadinone acetate, 3-α-acetoxy-chlormadinone acetate and 3-β-acetoxy-chlormadinone acetate and at least one insulin sensitiser in the form of a specific number of daily units A intended for uninterrupted, daily, oral administration to women, wherein the dosage form additionally contains 7-3 hormone-free daily units B containing only an insulin sensitiser as active ingredient intended for subsequent, uninterrupted, daily, oral administration to women, and wherein each daily unit A and each daily unit B contain the same insulin sensitizer and each daily unit B contains up to 50 wt. % of the quantity of the insulin sensitiser present in a daily unit A.